ketanserin has been researched along with Diabetic Angiopathies in 5 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 10.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
| "The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 6.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
| "Ketanserin treatment administered over a period of 8 weeks, decreased arterial pressure in patients with essential hypertension and, to a lesser extent, in diabetics, but not in normal subjects." | 5.27 | Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension. ( Beretta-Piccoli, C; Waser, M; Ziegler, WH, 1988) |
| "Ketanserin treatment administered over a period of 8 weeks, decreased arterial pressure in patients with essential hypertension and, to a lesser extent, in diabetics, but not in normal subjects." | 1.27 | Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension. ( Beretta-Piccoli, C; Waser, M; Ziegler, WH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerritsen, HA | 1 |
| Perquin, JW | 1 |
| de Smet, HL | 1 |
| Troost, FA | 1 |
| Kotora, OV | 1 |
| Pietraszek, MH | 1 |
| Takada, Y | 1 |
| Takada, A | 1 |
| Fujita, M | 1 |
| Watanabe, I | 1 |
| Taminato, A | 1 |
| Yoshimi, T | 1 |
| Janssens, M | 1 |
| Symoens, J | 1 |
| Robertson, MP | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Pasotti, C | 1 |
| Nicrosini, S | 1 |
| Lazzari, P | 1 |
| Corradi, L | 1 |
| Waser, M | 1 |
| Ziegler, WH | 1 |
| Beretta-Piccoli, C | 1 |
1 review available for ketanserin and Diabetic Angiopathies
| Article | Year |
|---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
1 trial available for ketanserin and Diabetic Angiopathies
| Article | Year |
|---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
4 other studies available for ketanserin and Diabetic Angiopathies
| Article | Year |
|---|---|
Continuous imaging of regional blood flow in peripheral vascular disease using Krypton-81m: effect of Ketanserin, a new selective serotonin antagonist.
Topics: Animals; Arteriosclerosis Obliterans; Cats; Diabetic Angiopathies; Female; Humans; Hyperemia; Ketans | 1983 |
Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Binding Sites; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabe | 1992 |
Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucose; Glucose Tol | 1990 |
Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension.
Topics: Adult; Blood Pressure; Diabetic Angiopathies; Female; Humans; Hypertension; Ketanserin; Male; Middle | 1988 |